論文
英文
A case of acute and severe thrombocytopenia due to re-administration of rifampicin. J Infect Chemother 2011 Apr;17(2):288-90.
Mori M, Izawa K, Fujikawa T, Uenami T, Sugano T, Kagami S, Namba Y, Yano Y, Yoneda T, Kitada S, Yamaguchi T, Yokota S and Maekura R.
Long-term radiographic outcome of nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Int J Tuberc Lung Dis. 2012 May;16(5):660-4.
Kitada S, Uenami T, Yoshimura K, Tateishi Y, Miki K, Miki M, Hashimoto H, Fujikawa T, Mori M, Matsuura K, Kuroyama M, Maekura R.
Anaphylaxis due to intravenous levofloacin with tolerance to garenoxacin. Intern Med. 2012 Jul;51(13):1769-72.
Fukushima K, Nakatsubo M, Noda M, Uenami T, Hayama Y, Tsuruta N, Oniki S, Saito Y, Niju T, Ikeda T.
A 46-year-old woman with atelectasis from an endobronchial tumor. Chest. 2013 Apr;143(4):1170-3.
Uenami T, Kijima T, Ayata M, Hayama Y, Tsuruta N, Saito Y, Niju T, Higaki N, Ikeda T.
Pulmonary Disease Caused by Rapidly Growing Mycobacteria: A Retrospective Study of 44 Cases in Japan. Respiration. 2013 Aug;85(4):305-11.
Yano Y, Kitada S, Mori M, Kagami S, Taguri T, Uenami T, Namba Y, Yoneda T, Yokota S, Maekura R.
Nuclear survivin expression in small cell lung cancer. Anticancer Res. 2015 May;35(5):2935-9.
Yano Y, Otsuka T, Hirano H, Uenami T, Satomi A, Kuroyama M, Niinaka M, Yoneda T, Kimura H, Mori M, Yamaguchi T, Yokota S.
Sorafenib treatment for patients with RET fusion-positive non-small cell lung cancer.Lung Cancer 2016 Dec;93:43-6.
Horiike A, Takeuchi K, Uenami T, Kawano Y, Tanimoto A, Kaburaki K, Tambo Y, Kudo K, Yanagitani N, Ohyanagi F, Motoi N, Ishikawa Y, Horai T, Nishio M.
Case series of pleomorphic carcinomas of the lung treated with nivolumab.Thorac Cancer. 2017 Nov; 8(6): 724–728.
Kanazu M, Uenami T, Yano Y, Nakatsubo S, Hosono Y, Ishijima M, Akazawa Y, Yamaguchi T, Urasaki K, Mori M, Yokota S.
Vitiligo in a patient with lung adenocarcinoma treated with nivolumab: A case report. Lung Cancer 2017 Jul ;109:42-44
Uenami T, Hosono Y, Ishijima M, Kanazu M, Akazawa Y, Yano Y, Mori M, Yamaguchi T, Yokota S.
Carboplatin plus weekly nanoparticle albumin-bound paclitaxel in elderly patients with previously untreated advanced squamous non-small-cell lung cancer selected based on Mini Nutritional Assessment short-form scores: a multicenter phase 2 study. Cancer Chemotherapy and Pharmacology 2017 Jul 80:461–467
Shiroyama T, Tamiya M, Minami S, Takata S, Masuhiro K, Futami-Nishijima Y, Uenami T, Mori M, Koba T, Matsuki T, Takimoto T, Suzuki H, Okamoto N, Komuta K, Hirashima T, Kumanogoh A & Kijima T.
Phase II trial of induction chemotherapy of pemetrexed plus split-dose cisplatin followed by pemetrexed maintenance for untreated non-squamous non-small-cell lung cancer. Cancer Chemother Pharmacol. 2018 Jul ;82(1):111-117.
Koba T, Minami S, Nishijima-Futami Y, Masuhiro K, Kimura H, Futami S, Yaga M, Mori M, Kagawa H, Uenami T, Kohmo S, Otsuka T, Yamamoto S, Komuta K, Kijima T.
Post-progression survival after cessation of treatment with nivolumab for advanced non-small cell lung cancer: A retrospective study. PLoS One. 2018 Aug 28;13(8).
Yano Y, Kurebe H, Edahiro R, Hosono Y, Nakatsubo S, Nishida K, Sawa N, Ishijima M, Uenami T, Kanazu M, Akazawa Y, Yamaguchi T, Mori M.
Efficacy of anti-PD-1/PD-L1 antibodies after discontinuation due to adverse events in non-small cell lung cancer patients (HANSHIN 0316). BMC Cancer. 2018 Oct 3;18(1):946.
Tachihara M, Negoro S, Inoue T, Tamiya M, Akazawa Y, Uenami T, Urata Y, Hattori Y, Hata A, Katakami N, Yokota S.
Clinical implications of monitoring nivolumab immunokinetics in non–small cell lung cancer patients Clinical implications of monitoring nivolumab immunokinetics in non-small cell lung cancer patients. JCI Insight. 2018 Oct 4;3(19).
Osa A, Uenami T, Koyama S, Fujimoto K, Okuzaki D, Takimoto T, Hirata H, Yano Y, Yokota S, Kinehara Y, Naito Y, Otsuka T, Kanazu M, Kuroyama M, Hamaguchi M, Koba T, Futami Y, Ishijima M, Suga Y, Akazawa Y, Machiyama H, Iwahori K, Takamatsu H, Nagatomo I, Takeda Y, Kida H, Akbay EA, Hammerman PS, Wong KK, Dranoff G, Mori M, Kijima T, Kumanogoh A.
Hyperprogressive disease in patients with non-small cell lung cancer treated with nivolumab: A case series. Thorac Cancer. 2018 Dec;9(12):1782-1787.
Kanazu M, Edahiro R, Krebe H, Nishida K, Ishijima M, Uenami T, Akazawa Y, Yano Y, Yamaguchi T, Mori M.
Two cases of response to pembrolizumab in epidermal growth factor receptor mutated lung adenocarcinoma patients with programmed death-ligand 1 overexpression. Ann Transl Med. 2018 Nov;6(22):444.
Uenami T, Ishijima M, Kanazu M, Kurebe H, Edahiro R, Nishida K, Akazawa Y, Yano Y, Yamaguchi T, Mori M.
Febrile neutropenia with bacterial paronychia. Clin Case Rep. 2018 Mar; 6(3): 543–544.
Hosono Y, Uenami T, Yano Y, Mori M.
Radiation Pneumonitis with Eosinophilic Alveolitis in a Lung Cancer Patient. Intern Med. 2018 May 1; 57(9): 1281–1285.
Hosono Y, Sawa N, Nakatsubo S, Ishijima M, Uenami T, Kanazu M, Akazawa Y, Yano Y, Mori M, Yamaguchi T, Yokota S.
Continued administration of pembrolizumab for adenocarcinoma of the lung after the onset of fulminant type 1 diabetes mellitus as an immune-related adverse effect: A case report. Thoracic Cancer. 2019 May;10(5):1276-1279.
Edahiro R, Ishijima M, Kurebe H, Nishida K, Uenami T, Kanazu M, Akazawa Y, Yano Y, Mori M.
Monitoring antibody binding to T cells in a pembrolizumab-treated patient with lung adenocarcinoma on hemodialysis. Thorac Cancer. 2019 Nov;10(11):2183-2187.
Osa A, Uenami T, Naito Y, Hirata H, Koyama S, Takimoto T, Shiroyama T, Futami S, Nakatsubo S, Sawa N, Yano Y, Nagatomo I, Takeda Y, Mori M, Kida H, Kumanogoh A.
Safety and effectiveness of pirfenidone combined with carboplatin‐based chemotherapy in patients with idiopathic pulmonary fibrosis and non‐small cell lung cancer: A retrospective cohort study. Thorac Cancer. 2020 Nov; 11(11): 3317–3325.
Yamamoto Y, Yano Y, Kuge T, Okabe F, Ishijima M, Uenami T, Kanazu M, Akazawa Y, Yamaguchi T, Mori M.
EGFR‐mutant lung adenocarcinoma associated with antisynthetase syndrome successfully treated with Osimertinib. Thorac Cancer. 2021 May ;12(9):1441–1444.
Hara R, Kanazu M, Iwai A, Kuge T, Ishijima M, Uenami T, Akazawa Y, Yano Y, Yamaguchi T, Mori M.
Expectoration of tonsillar metastasis of pulmonary pleomorphic carcinoma after pseudoprogression: A case report. Thorac Cancer. 2021 Jun;12(12):1935-1939
Kuge T, Okabe F, Yamamoto Y, Ishijima M, Uenami T, Kanazu M, Akazawa Y, Yano Y, Yamaguchi T, Mori M.
Bronchial ethanol injection therapy for airway obstruction in lung cancer patients. Respirology Case Reports.2021 Sep;9(9)
Okabe F, Yano Y, Kuge T, Uenami T, Kanazu M, Mori M.
Osimertinib as first-line treatment for advanced epidermal growth factor receptor mutation–positive non–small-cell lung cancer in a real-world setting (OSI-FACT). European Journal of Cancer.2021 Dec; 159:144-153
Sakata Y, Sakata S, Oya Y, Tamiya M, Suzuki H, Shibaki R, Okada A, Kobe H, Matsumoto H, Yokoi T, Sato Y, Uenami T, Saito G, Tsukita Y, Inaba M, Ikeda H, Arai D, Maruyama H, Hara S, Tsumura S, Morinaga J, Sakagami T.
Classification and regression tree for estimating predictive markers to detect T790M mutations after acquired resistance to first line EGFR-TKI: HOPE-002. Invest New Drugs. 2022 Jan ;28.
Tamiya M, Fujikawa K, Suzuki H, Yokoyama T, Uenami T, Tamiya A, Sato Y, Saito G, Uchida J, Morita M, Hirashima T, Fukuda Y, Kanazu M, Hosoya K, Suzuki T, Ueno K, Fujimoto D, Kumagai T, Teramukai S.
Real-world survey of pneumonitis and its impact on durvalumab consolidation therapy in patients with non-small cell lung cancer who received chemoradiotherapy after durvalumab approval (HOPE-005/CRIMSON). Lung Cancer.2021 Nov; 161;86-93.
Saito G, Oya Y, Taniguchi Y, Kawachi H, Daichi F, Matsumoto H, Iwasawa S, Suzuki H, Niitsu T, Miyauchi E, Yokoi T, Yokoyama T, Uenami T, Sakata Y, Arai D, Okada A, Nagata K, Teraoka S, Kokubo M.
和文
カルボプラチン，パクリタキセル，ベバシズマブ併用療法が奏効した肉腫様肺癌と考えられた1例．日呼吸会誌, 2011;49(4):304-8
菅野哲平、森 雅秀、灘波良信、上浪 健、各務慎一、横田総一郎
脳膿瘍と細菌性髄膜炎を併発した肺癌多発脳転移の１剖検例．肺癌 2011;51(4):247-52
奥山貴子、森 雅秀、上浪 健、各務慎一、上田佳世、横田総一郎
Trousseau症候群を伴った肺癌の1例． 日本呼吸器学会誌2012;1(4): 363-7
上浪 健、森 雅秀、木村紀久、各務慎一、米田勉、横田総一郎
化学療法開始後に急激な全身浮腫を来たしたACTH産生肺小細胞癌の1例. 肺癌 2012;52(4):387-92
福島 清春、野田 昌宏、葉山 善友、上浪 健、鶴田 直敏、齋藤 宜之、二重 隆史、池田 聡之.
Docetaxel投与で過敏反応を起こしたがNab-Paclitaxel投与は可能であった肺扁平上皮癌の1例. 癌と化学療法 2015 Mar;42(3):375-7.
上浪 健、森 雅秀、揚塩 文崇、香川 浩之、松井 秀記、里見 明俊、新中 学、木村 裕美、 矢野 幸洋、米田 勉、山口 俊彦、横田 総一郎.
crizotinibで重篤な肝機能障害を起こしたがalectinibは投与可能であったALK陽性の肺扁平上皮癌の1例. 肺癌 2015 ;55(1):53-8
上浪 健、揚塩 文崇、松井 秀記、里見 明俊、米田 勉、森 雅秀
気管支胸腔瘻を併発した肺放線菌症の1例．気管支学2016;38(1):26-31.
松井秀記、押谷洋平、上浪 健、矢野幸洋、米田 勉、好村研二、三木啓資、北田清悟、森 雅秀．
原発巣と転移巣がともに当初から薄壁空洞を呈した肺扁平上皮癌の 1 例. 肺癌2016;56(5):385-389
大塚倫之、細野裕貴、石島見佳子、上浪 健、矢野幸洋、森 雅秀.
化学放射線療法後デュルバルマブの投与回避要因（TOPGAN2020-01）. 肺癌 2020;60(7): 966-971
有安 亮, 内堀 健, 田中 寿志, 宮内 栄作, 川嶋 庸介, 大柳 文義, 堀池 篤, 酒谷 俊雄, 齊木 雅史, 丹保 裕一, 谷本 梓, 園田 智明, 神山 潤二, 上浪 健, 工藤 慶太, 土屋 裕子, 西尾 誠人
原著
腫瘍随伴症候群としてのTrousseau症候群．呼吸と循環 2014; 62(12): 1195-1200.
上浪 健、木村紀久、森 雅秀
